Pharmaceutical Raw Materials
Veterinary API
Antiallergic Drugs
Hormones and Endocrine Drugs
Drug Metabolism
Pharmaceutical Intermediates
Synthetic Anti Infective Drugs
Specialty Drugs
Vitamins and Minerals Medicines
Feed Drug Additive
Antineoplastic Agents
Nervous System Drugs
Respiratory Drugs
Diagnostic Agents
Anti Stress Drugs
Antipyretic Analgesics
Antiparasitic Drugs
Circulatory System Drugs
Biochemicals
Blood System Drugs
Immune System Medication
Pharmaceutical Excipients
Fluid, Electrolyte, and Acid-Base Balance
Urinary System Drugs
Antibiotics
Anesthetic Agents
Inhibitors
Other Chemical Drugs
Digestive System Drugs
CAS:123-31-9
Molecular Formula:C6H6O2
Alias
More Information
1,4-Benzenediol; Quinol; Hydroxyquinone; Hydrochinone; 1,4-Dihydroxybenzene; Docetaxel; 1,4-Dihydroxyanthone; 1,4-Dihydroxyanthron; 1,4-Dihydroxy-Benzene; 1,4-Dihydroxy-Benzol; 1,4-Dihydroxy-Xanthen-9-On; 1,4-Dihydroxy-Xanthen-9-One; 1,4-Dihydroxyxanthon; 9H-Xanthen-9-One,1,4-Dihydroxy; P-Benzenediol; P-Dihydroxybenzene
Brief Introduction
Produced as an inhibitor, an antioxidant, and an intermediate in the synthesis of dyes, motor fuels, and oils; in photographic processing; and naturally in certain plant species, Hydroquinone is a phenol derivative with antioxidant properties that can cause toxicity in several organs, notably the kidney. Used as a topical treatment for skin hyperpigmentation and in various cosmetic products, it is metabolized mainly to glutathione conjugates and forms mutagenic DNA adducts in in-vitro systems.
Suppliers
View More Vendors (4） >
CAS:127-08-2
Molecular Formula:C2H3KO2
Alias
More Information
Acetic Acid,Potassium Salt; Anhydrous Potassium Acetate
Brief Introduction
The product is used as dehydrating agent, fiber treatment agent and analytical reagent. As a Penicillium culture medium in the pharmaceutical industry, potassium acetate should be used as raw material in the production of cortisone acetate, hydrogenated prednisone birch acetate, dexamethasone acetate, betamethasone acetate and skin relaxed acetate.
Suppliers
View More Vendors (4） >
CAS:129453-61-8
Molecular Formula:C32H47F5O3S
Alias
More Information
Faslodex (Trade Name); (7R,8R,9S,13S,14S,17S)-13-Methyl-7-[9-(4,4,5,5,5-Pentafluoropentylsulfinyl)Nonyl]-6,7,8,9,11,12,14,15,16,17-Decahydrocyclopenta[A]Phenanthrene-3,17-Diol; (7A,17B)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)Sulfinyl]Nonyl]Estra-1,3,5(10)-Triene-3,17-Diol; 7A,17B-[9[(4,4,5,5,5-Pentafluoropentyl)Sulfinyl]Nonyl]Estra-1,3,5(10)-Triene-3,17-Diol; (7Alpha,17Beta)-Nonyl); Estra-1,3,5(10)-Triene-3,17-Diol,7-(9-((4,4,5,5,5-Pentafluoropentyl)Sulfinyl); 7-[9-[(4,4,5,5,5-Pentafluoropentyl)Sulfinyl]Nonyl]- (7α,17β)-Estra-1,3,5(10)-Triene-3,17-Diol
Brief Introduction
Fluticasone is an intramuscular injection developed by AstraZeneca. It was approved by the food and Drug Administration in April 2002 to treat estrogen receptor positive metastatic breast cancer in postmenopausal women whose disease is still deteriorating after anti estrogen therapy. Many breast cancer cells have estrogen receptor (ER), estrogen can stimulate the growth of such tumors. Fluvestrant is a "pure" estrogen receptor antagonist without partial estrogen like agonistic effect. It inhibits estrogen signal pathway by binding, blocking and down regulating er. It can competitively bind with ER. Its affinity with Er is close to estrogen, 100 times that of tamoxifen. It is the only anti estrogen drug that can be widely used in clinic after tamoxifen fails, Because the drug is endocrine therapy and will not cause common adverse reactions of chemotherapy, it has good patient compliance.
Suppliers
View More Vendors (4） >
CAS:134523-03-8
Molecular Formula:C66H68CaF2N4O10
Alias
More Information
Atorvastatin Ca; Atorvastatin Calcium Salt Anhydride; Calcium (3R,5R)-7-(2-(4-Fluorophenyl)-5-Isopropyl-3-Phenyl-4-(Phenylcarbamoyl)-1H-Pyrrol-1-Yl)-3,5-Dihydroxyheptanoate; Lipitor; Atorvastatin Calcium Salt; [R-(R*, R*)]-7-[2-(4-Fluorophenyl)-5-(1-Methylethyl)-3-Phenyl-4-(Phenylaminocarbonyl)-1H-Pyrrol-1-Yl]-3,5-Dihydroxy-Heptanoic Acid Calcium Salt; (3R,5R)-7-(2-(4-Fluorophenyl)-5-Isopropyl-3-Phenyl-4-(Phenylcarbamoyl)-1H-Pyrrol-1-Yl)-3,5-Dihydroxyheptanoic Acid Calcium; (3R,5R)-7-(2-(4-Fluorophenyl)-5-Isopropyl-3-; (R,Dr)-2-(4-Fluorophenyl)-,D-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)Carbonyl]-1H-Pyrrole-1-Heptanoic Acid Calcium; Atorvastatin Calcium Manufacturers
Brief Introduction
Atorvastatin calcium is a HMG CoA reductase inhibitor. Mainly through inhibiting the synthesis of HMGCoA reductase, thus inhibiting the synthesis of cholesterol in vivo, reducing the content of serum low density lipoprotein cholesterol and triglyceride. Atorvastatin calcium can inhibit the synthesis of cholesterol, interfere with the production of lipoprotein, reduce the level of serum total cholesterol, effectively reduce the level of serum triglyceride, but also increase the level of serum high-density lipoprotein cholesterol. It can reduce the plasma LDL-C level in some homozygous familial hypercholesterolemia patients, but this type of population has little response to other lipid-lowering drugs. It is clinically used for primary hypercholesterolemia, mixed hyperlipidemia, hypertriglyceridemia, homozygous familial hypercholesterolemia and prevention and treatment of atherosclerosis.
Suppliers
View More Vendors (4） >
CAS:144701-48-4
Molecular Formula:C33H30N4O2
Alias
More Information
4'-[{1,4'-Dimethyl-2'-Propyl[2,6'-Bi-1H-Benzimiaszol]-1'Yl}-Methyl}-1,1'-Biphenyl-2-Caroxylic Acid Dimethyl Ethyl Ester; 4'-[{1,4'-Dimethyl-2'-Propyl[2,6'-Bi-1H-Benzimiaszol]-1'Yl}-Methyl}-1,1'-Biphenyl-2-Caroxylic Acid; 4''-(1,7''-Dimethyl-2''-Propyl-1H-[2,5'']Bibenzoimidazolyl-3''-Ylmethyl)-Biphenyl-2-Carboxylic Acid; 4-Chloromethyl-5-Methyl-1,3-Dioxol-2-Tone; 4'-(1,7'-Dimethyl-2'-Propyl-1H-; Bibr 277, 4μ[(1,4μ-Dimethyl-2μ-Propyl[2,6μ-Bi-1H-Benzimidazol]-1μ-Yl)Methyl][1,1μ-Biphenyl]-2-Carboxylic Acid; 4'-[[4-Methyl-6-(1-Methyl-2-Benzimidazolyl)-2-Propyl-1-Benzimidazolyl]Methyl]-2-Biphenylcarboxylic Acid; Telmisartan,4′[(1,4′-Dimethyl-2′-Propyl[2,6′-Bi-1H-Benzimidazol]-1′-Yl)Methyl][1,1′-Biphenyl]-2-Carboxylic Acid, Bibr 277
Brief Introduction
Telmisartan is a new type of antihypertensive drug, which is a specific angiotensin II receptor antagonist for the treatment of essential hypertension. The substitution of angiotensin Ⅱ receptor for at Ⅰ receptor subtype has high affinity binding. Telmisartan has no agonist effect at the at I receptor site, but selectively binds to at I receptor, which is persistent. It has no affinity for other receptors. The function of other receptors mentioned above is unknown, and the possible receptor hyperstimulation effect caused by telmisartan is also unknown. Telmisartan did not inhibit plasma renin or block ion channels. It did not inhibit angiotensin converting enzyme II, which could also degrade bradykinin induced adverse reactions.
Suppliers
View More Vendors (4） >
Inquiry (
10
/ 10
)
Clear All
Sign In
Error!